Loading organizations...
Loading organizations...
Clinical-stage therapies for chronic obstructive pulmonary disease.
AirNexis Therapeutics has raised $200.0M across 1 funding round.
AirNexis Therapeutics has raised $200.0M in total across 1 funding round.
AirNexis Therapeutics has raised $200.0M in total across 1 funding round.
AirNexis Therapeutics's investors include Anna Chen, Enavate Sciences, Longitude Capital, Evan Caplan, Jill Carroll.
AirNexis Therapeutics has raised $200.0M across 1 funding round. Most recently, it raised $200.0M Series A in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 12, 2026 | $200.0M Series A | Anna Chen | Enavate Sciences, Longitude Capital, Evan Caplan, Jill Carroll |